99 studies found for:    aspirin | United States, New York | Studies with Male Participents
Show Display Options
Download search resultsDownload the search results for:
aspirin | United States, New York | Studies with Male Participents (99 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Conditions: Heart Disease;   Stroke;   Ischemic Heart Disease;   Myocardial Infarction
Interventions: Drug: aspirin;   Drug: Warfarin
2 Active, not recruiting A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Condition: Moderate Risk of CVD
Interventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
3 Recruiting [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Conditions: Acute Ischaemic Stroke;   Transient Ischaemic Attack.
Interventions: Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
4 Completed Secondary Prevention of Small Subcortical Strokes Trial
Conditions: Cerebrovascular Accident;   Hypertension
Interventions: Drug: aspirin;   Drug: clopidogrel;   Other: Target of Blood Pressure;   Other: placebo
5 Completed Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Condition: Colorectal Cancer
Intervention: Drug: acetylsalicylic acid
6 Recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
7 Recruiting Aspirin in Reducing Events in the Elderly
Conditions: Functional Disability;   Dementia;   Heart Disease;   Stroke;   Cancer;   Bleeding
Interventions: Drug: 100 mg enteric-coated aspirin;   Drug: Placebo
8 Recruiting Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Condition: Cancer Patients First-ever Acute Ischemic Stroke
Interventions: Drug: Enoxaparin;   Drug: Aspirin
9 Recruiting Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
Condition: Acute Migraine
Interventions: Drug: Acetaminophen 250 mg and Aspirin 250 mg;   Drug: Placebo
10 Terminated Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
11 Not yet recruiting ASPREE Cancer Endpoints Study
Condition: Cancer
Interventions: Drug: Aspirin;   Drug: Placebo
12 Recruiting Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Condition: Prevention & Control
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
13 Completed Warfarin and Antiplatelet Therapy in Chronic Heart Failure
Condition: Heart Failure
Interventions: Drug: Warfarin titrated to an INR of 2.5-3.0;   Drug: Aspirin;   Drug: Clopidogrel 75
14 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
15 Active, not recruiting
Has Results
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic acid
16 Active, not recruiting The Dual Antiplatelet Therapy Study (DAPT Study)
Condition: Coronary Artery Disease
Interventions: Drug: Placebo & Aspirin;   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin
17 Completed
Has Results
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Commercially-available Aspirin
18 Completed XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Conditions: Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Intervention: Drug: DAPT
19 Completed
Has Results
Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
Condition: Pain, Migraine
Interventions: Drug: Aspirin, acetaminophen and caffeine;   Drug: Sumatriptan;   Drug: Placebo
20 Active, not recruiting Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years